Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Takashi Saotome"'
Autor:
Daisuke Kawakita, Toshitaka Nagao, Hideaki Takahashi, Satoshi Kano, Yoshitaka Honma, Hideaki Hirai, Natsuki Saigusa, Kohei Akazawa, Kaori Tani, Hiroya Ojiri, Kiyoaki Tsukahara, Hiroyuki Ozawa, Kenji Okami, Takahito Kondo, Takafumi Togashi, Chihiro Fushimi, Tomotaka Shimura, Akira Shimizu, Isaku Okamoto, Takuro Okada, Yorihisa Imanishi, Yoshihiro Watanabe, Kuninori Otsuka, Akihiro Sakai, Koji Ebisumoto, Yuichiro Sato, Keisuke Yamazaki, Yushi Ueki, Toyoyuki Hanazawa, Yuki Saito, Mizuo Ando, Takashi Matsuki, Masato Nakaguro, Yukiko Sato, Makoto Urano, Yoshitaka Utsumi, Shinji Kohsaka, Takashi Saotome, Yuichiro Tada
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 14 (2022)
Background: The efficacy and safety of human epidermal growth factor receptor 2 (HER2)-targeted therapy and androgen deprivation therapy (ADT) for locally advanced or recurrent or metastatic (LA/RM) salivary duct carcinoma (SDC) have been reported in
Externí odkaz:
https://doaj.org/article/331f3b59c5064a0298c40bb36a684230
Autor:
Gerben Lassche, Yuichiro Tada, Carla M. L. van Herpen, Marianne A. Jonker, Toshitaka Nagao, Takashi Saotome, Hideaki Hirai, Natsuki Saigusa, Hideaki Takahashi, Hiroya Ojiri, Adriana C. H. van Engen-Van Grunsven, Jack A. Schalken, Chihiro Fushimi, Gerald W. Verhaegh
Publikováno v:
Cancers, Vol 13, Iss 14, p 3527 (2021)
Patients suffering from recurrent or metastatic (R/M) salivary duct carcinoma (SDC) are often treated with combined androgen blockade (CAB). However, CAB frequently fails, resulting in a worse prognosis. Therefore, biomarkers that can predict treatme
Externí odkaz:
https://doaj.org/article/f3235e873d024cad803f326163b0b5e2
Autor:
Ryohei, Ono, Yuta, Iwai, Tatsuro, Yamazaki, Hidehisa, Takahashi, Yasuhiko, Hori, Kenichi, Fukushima, Takashi, Saotome
Publikováno v:
Internal Medicine. 61:2973-2979
Immune checkpoint inhibitors (ICIs) are complicated by immune-related adverse events (irAEs), such as myositis, myocarditis, and myasthenia gravis (MG). Anti-titin antibody and anti-voltage-gated potassium channel Kv1.4 antibody are anti-striated ant
Autor:
KEISHO CHIN, DAISUKE TAKAHARI, RYOHEI KAWABATA, HISASHI HOSAKA, SO SAITOU, TAKESHI SHIRAISHI, HIROSHI YABUSAKI, MASAHIRO GOTO, MASATO NAKAMURA, HIROSHI IMAMURA, YOSHIAKI SHINDO, FUMIO NAGASHIMA, WATARU ICHIKAWA, TAKASHI SAOTOME, WATARU YAMAMOTO, NAOKI ISHIZUKA, KENSEI YAMAGUCHI
Publikováno v:
Anticancer research. 42(5)
Safety of combination chemotherapy using platinum and fluorouracil has not been evaluated adequately for advanced gastric cancer (AGC) in elderly patients.We initiated a phase II study to evaluate the efficacy and safety of capecitabine plus oxalipla
Autor:
Hideaki Takahashi, Yuichiro Tada, Shuhei Yamada, Hiroya Ojiri, Hideaki Hirai, Takashi Matsuki, Kaori Tani, Kohei Akazawa, Robert Yoshiyuki Osamura, Shin Etsu Kamata, Daisuke Kawakita, Toshitaka Nagao, Chihiro Fushimi, Tatsuo Masubuchi, Kouki Miura, Takashi Saotome
Publikováno v:
Journal of Clinical Oncology. 37:125-134
Purpose Clinical evidence demonstrating the effectiveness of systemic therapy for advanced salivary duct carcinoma (SDC) is lacking because of the disease’s rarity. We assessed the efficacy and toxicity of trastuzumab plus docetaxel in patients wit
Autor:
Gerald W. Verhaegh, Toshitaka Nagao, Chihiro Fushimi, Gerben Lassche, Natsuki Saigusa, Hideaki Takahashi, Carla M.L. van Herpen, Adriana C. H. van Engen-van Grunsven, Takashi Saotome, Yuichiro Tada, Marianne A. Jonker, Jack A. Schalken, Hideaki Hirai, Hiroya Ojiri
Publikováno v:
Cancers, Vol 13, Iss 3527, p 3527 (2021)
Cancers, 13
Cancers
Volume 13
Issue 14
Cancers, 13, 14
Cancers, 13
Cancers
Volume 13
Issue 14
Cancers, 13, 14
Simple Summary Androgen receptor signaling seems pivotal in aggressive salivary duct carcinoma. However, androgen deprivation therapy (ADT) frequently fails, emphasizing the need for biomarkers to predict treatment response. Here, the activities of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::458b686d49997fc4fdf8245a18571397
https://doi.org/10.3390/cancers13143527
https://doi.org/10.3390/cancers13143527
Autor:
Hideaki Hirai, Kouki Miura, Kiyoaki Tsukahara, Tatsuo Masubuchi, Takashi Matsuki, Chihiro Fushimi, Hideaki Takahashi, Natsuki Saigusa, Takashi Saotome, Kazutomo Niwa, Yuichiro Tada, Masashi Okazaki, Takuro Okada, Hirooki Matsui, Isaku Okamoto, Sho Iwaki, Toshitaka Nagao, Shinichi Okazaki, Daisuke Kawakita, Kenji Hanyu, Nobuhiko Oridate, Keisuke Yamazaki
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-13 (2020)
Although immune-checkpoint inhibitors (ICIs) are effective against various cancers, little is known regarding their role in salivary gland carcinoma (SGC) treatment. Therefore, we evaluated the efficacy and safety of nivolumab monotherapy in patients
Autor:
Kouki Miura, Shin-etsu Kamata, Chihiro Fushimi, Hideaki Takahashi, Hideaki Hirai, Takashi Matsuki, E. Hoshino, Toshitaka Nagao, Tatsuo Masubuchi, Hiroya Ojiri, Takashi Saotome, Daisuke Kawakita, Yuichiro Tada
Publikováno v:
Annals of Oncology. 29:979-984
Background There is no standard first-line chemotherapy for recurrent/metastatic (RM) or unresectable locally advanced (LA) salivary gland carcinoma (SGC). Patients and methods We conducted a single institution, open-label, single arm, phase II trial
Autor:
Masako Inoue, Takashi Saotome
Publikováno v:
Annals of Oncology. 32:S354
Autor:
Toshitaka Nagao, Tatsuo Masubuchi, Takashi Saotome, Hideaki Takahashi, Hideaki Hirai, Chihiro Fushimi, Natsuki Saigusa, Yuichiro Tada, Kouki Miura, Daisuke Kawakita, Daisuke Baba, Takuro Okada, Takashi Matsuki
Publikováno v:
Annals of Oncology. 30:v471-v472
Background A phase II trial of combined androgen blockade (CAB) in patients with advanced androgen receptor (AR)–positive salivary gland carcinoma (SGC) showed 40% of the overall response rate. However, biomarkers which predict survival in this pop